Wonzigene Biotechnology (Shanghai) Co., LTD is a wholly owned subsidiary of Zhejiang Oriental Gene Biological Products Co., LTD. (Science and Technology Board code: 688298).
01
Zhejiang East Gene Biological Products Co., Ltd. is committed to the research and development, production and sales of in vitro diagnostic reagents. The company’s products cover three major fields of rapid detection, molecular diagnosis and liquid chip, mainly sold to Europe and the United States and other countries. In this COVID-19 epidemic, after the hard work of all the staff, the first batch of products related to COVID-19 testing were developed and highly recognized by WHO, which made an outstanding contribution to the fight against the epidemic at home and abroad, and achieved double growth in performance.
02
Wonzigene Biotech (Shanghai) Co., Ltd. is mainly engaged in the research and development, manufacturing and production of liquid chip technology platform to realize the important strategic development blueprint of Oriental Gene. Research, development and production of molecular and immune in vitro diagnostic reagents based on liquid chip technology.
03
The company’s existing production plant area of 3500 square meters, located in Shanghai Jiading Industrial zone; Product research and development Center laboratory 1000 square meters, located in Shanghai Minhang District Zizhu high-tech Industrial Park, and Shanghai Jiaotong University, East China Normal University adjacent to famous universities. At present, the center has three well-known professors in materials science, immunology and molecular biology, and several doctoral and postgraduate students.